Reports from the States

ARIZONA
Arizona methadone treatment programs are evaluating HIV rates from programs in Phoenix and Tucson. It appears that the HIV rate in these programs is 2.5%. These treatment programs also report Hepatitis C rates to be above 75%, which appears to be consistent in studies of methadone treatment programs testing for HCV. In addition the providers also report that LAAM is being used in a larger number of clinics for a greater number of patients, demonstrating favorable results. (Editors note: It appears that more methadone treatment programs are finding successful results in using LAAM with increasing numbers of patients.)

CONNECTICUT
Thomas Kirk, Jr. (Deputy Commissioner of the Connecticut Department of Mental Health & Addiction Services) has convened an Opiate Substitution Therapy Advisory Committee. The primary charge of the Committee is to develop appropriate standards and protocols for a pilot study, which will evaluate the efficacy of providing methadone treatment in physician offices. Paul McLaughlin and Richard Bilangi, Association Board members representing Connecticut’s methadone providers, have been appointed by Dr. Kirk as members of this Advisory Committee.

The pilot study is the result of legislation, which was approved by the Connecticut legislature during 1997 and signed into law by Governor Rowland. This legislation also represented the first state legislation in the United States, specifically referencing the Guidelines of the American Methadone Treatment Association, Inc., which have also been printed in their entirety in this edition.

CSAT is providing partial funding in developing this project and 60 patients will be involved in the study, with 30 in a control group, remaining in the methadone treatment program and the other 30 patients being referred to physician settings. These patients will remain in the pilot project for 6 months. The significance of this pilot is enormous since other states are interested in learning from the results of this pilot as they develop plans to refer stabilized methadone maintained patients to physician settings.

MASSACHUSETTS
In a cooperative effort the Massachusetts Methadone Treatment Providers Association, Alcoholism and Drug Abuse Association (ADAA), Department of Public Health, Bureau of Substance Abuse Services (DPH/BSAS), and Massachusetts Behavioral Health Partnership (MBHP) – MCO for Massachusetts Health Medicaid) developed a new Medicaid rate structure for methadone counseling services. The negotiations resulted in a reimbursement structure that brought parity to methadone counseling services with the reimbursement structure for outpatient substance abuse and mental health treatment in the Commonwealth. In addition, rates for new services were developed and approved allowing for community support services and psychopharmacology services.

The Massachusetts Methadone Treatment Providers Association also lead a collaborative effort with the DPH, ADAA, and ADCARE in offering its first statewide methadone conference on May 13, 1998. The conference was well attended with representation from drug free substance abuse, mental health and community health care providers. The American Methadone Treatment Association, DEA, State officials and providers came together to discuss the role and efficacy of opioid pharmacotherapies in the treatment of opioid dependence.

RHODE ISLAND
Rhode Island’s methadone treatment providers have been working to educate Family Court judges and child protective workers who are involved in working with methadone maintained patients in the judicial process. This statewide initiative has advanced a better understanding of methadone treatment services and is expected to yield favorable long term results. Based upon presentations to the Family Court system, Mark Parrino was recently asked to present two workshops to social workers in the child protective system and it was well received. Our colleagues in Rhode Island recommend that methadone providers in the 41 other states pursue such educational initiatives in their respective state’s family court and child protective systems.

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
  • View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
  • 💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
  • 💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
  • 3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
  • Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
  • Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2024 Conference, �The world’s premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

The 2024 AATOD Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. The registrants are decision-makers with purchasing power for their treatment centers and are looking for new products, services, and information to improve their patient treatment.

To become an exhibitor today —> https://bit.ly/48ZKMRX
  • TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION

💻 View the latest Conference Video Message from AATOD's President, Mark W. Parrino bit.ly/48y815w,
for the most up-to-date details regarding the upcoming #aatod2024 Conference -
The world's premier training conference event for the treatment of Opioid Use Disorder. #OUD 

Registration ➡️ www.aatodconference.com
  • TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION #aatod2024

TODAY is the last day to take advantage of the discounted registration rate. #aatod2024 is the world’s premier training conference event for the treatment of #OUD.

For registration and hotel information ➡️ bit.ly/3Ue57Q6.

We look forward to seeing you in Las Vegas!
  • #aatod2024 Conference Update. Comprehensive Listing/Descriptions of Workshops, Posters, and Hot Topic Roundtable Conference Sessions are now available ➡️ http://bit.ly/3Ue57Q6.

The workshop committee is pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines. You will hear from experts who will share the latest research and developments relating to opioid use disorders and treatment. The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships and collaborations, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, regulatory changes, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. For those newer to the field or those who want a refresher on the basics, we have once again included a “Foundations” track which will include selections on the fundamentals of medication assisted treatment.

The conference will continue to be the world’s premier training and education event for the treatment of opioid use disorders.  We hope to see you in Las Vegas!
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️ 
TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM

This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations.

We certainly hope that this is helpful and please let us know if you have any questions.
AVAILABLE 🗒️  TECHNICAL REVIEW OF SAMHSA’S FINAL REGULATIONS ➡️ bit.ly/3w71hOM This brief can be used by treatment providers and state officials as a quick reference in better understanding the salient policy issues that are contained in SAMHSA's new regulations. We certainly hope that this is helpful and please let us know if you have any questions.
5 days ago
View on Instagram |
1/10
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. 

We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication

https://youtu.be/i6u3qUS95jU
View the latest #aatod2024 Conference Video Message from the Host Committee Chair, Katro Henderson. We look forward to seeing you next month in Las Vegas for the world’s premier training conference event for the Treatment of Opioid Use Disorder. #OUD #somuchmorethanmedication https://youtu.be/i6u3qUS95jU
2 weeks ago
View on Instagram |
2/10
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW.

#ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
💻 Access the 3/27 SAMHSA Webinar Recording on 42 CFR Part 8, Clinical ➡️ bit.ly/3TIEZdW. #ICYMI This comprehensive webinar provided an overview of the rule changes and provided a discussion with SAMHSA regarding the implications of the changes.
2 weeks ago
View on Instagram |
3/10
💻 Webinar Recording is Now Available
AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative.  We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. 

➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
💻 Webinar Recording is Now Available AATOD is pleased to share the March 20th SAMHSA Webinar Recording on 42 CFR Part 8, Administrative. We encourage you to view this recording to assist you in determining how you will need to prepare for full implementation of these regulations. ➡ https://youtu.be/pgWZUpDhi94?si=obomo4LXRIwJPiC8
3 weeks ago
View on Instagram |
4/10
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone.

Register ➡️ bit.ly/3Vz1RPE
3/28 Expanding Access to #Methadone in Correctional Facilities will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the SAMHSA 2024 final rule on the use of methadone. Register ➡️ bit.ly/3Vz1RPE
4 weeks ago
View on Instagram |
5/10
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 

On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. 

In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  

REGISTER ➡ https://conta.cc/3TF9CSQ

View the final rule ➡ https://lnkd.in/e_iu-AtG.

There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. 

We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. 

This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW
(Director - CSAT’s Division of Pharmacologic Therapies).

The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
Invitation to SAMHSA Webinars on 42 CFR Part 8 💻 On February 2, 2024, the final rule for 42 CFR Part 8 was published. The effective date for these regulations is April 2, 2024, with an implementation date of October 2, 2024. In preparation for implementation of the revisions, SAMHSA will provide two preliminary webinars for OTPs.  The first will focus on administrative areas; the second will focus more on clinical content. These will be held on March 20th (from 2-3pm EST) and March 27th, 2024 (from 2- 3pm EST).  REGISTER ➡ https://conta.cc/3TF9CSQ View the final rule ➡ https://lnkd.in/e_iu-AtG. There will be an opportunity to receive an overview of the rule changes and discuss with SAMHSA the implications of the changes. We encourage you to attend these important meetings to assist you in determining how you will need to prepare for full implementation of these regulations. This webinar series will be moderated by Mark W. Parrino, MPA (AATOD President). Speakers include Yngvild Olsen, MD, MPH (Director - CSAT), Robert Baillieu, MD, MPH, FAAFP (Physician and Senior Advisor - SAMHSA/CSAT, and Patti Juliana, PhD, LCSW (Director - CSAT’s Division of Pharmacologic Therapies). The presentations will be followed by Q&A, and these webinars will become available to the public for On-Demand viewing via the AATOD website. Certificates of Attendance will be provided per request.
1 month ago
View on Instagram |
6/10
Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2024 Conference, �The world’s premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024

The 2024 AATOD Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. The registrants are decision-makers with purchasing power for their treatment centers and are looking for new products, services, and information to improve their patient treatment.

To become an exhibitor today —> https://bit.ly/48ZKMRX
Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2024 Conference, �The world’s premier training conference event for the Treatment of Opioid Use Disorder. #aatod2024 The 2024 AATOD Conference will attract over 1,600 physicians, social workers, nurses, counselors, program administrators, executive directors, and other treatment providers from many countries. The registrants are decision-makers with purchasing power for their treatment centers and are looking for new products, services, and information to improve their patient treatment. To become an exhibitor today —> https://bit.ly/48ZKMRX
1 month ago
View on Instagram |
7/10
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION

💻 View the latest Conference Video Message from AATOD's President, Mark W. Parrino bit.ly/48y815w,
for the most up-to-date details regarding the upcoming #aatod2024 Conference -
The world's premier training conference event for the treatment of Opioid Use Disorder. #OUD 

Registration ➡️ www.aatodconference.com
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION 💻 View the latest Conference Video Message from AATOD's President, Mark W. Parrino bit.ly/48y815w, for the most up-to-date details regarding the upcoming #aatod2024 Conference - The world's premier training conference event for the treatment of Opioid Use Disorder. #OUD Registration ➡️ www.aatodconference.com
2 months ago
View on Instagram |
8/10
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION #aatod2024

TODAY is the last day to take advantage of the discounted registration rate. #aatod2024 is the world’s premier training conference event for the treatment of #OUD.

For registration and hotel information ➡️ bit.ly/3Ue57Q6.

We look forward to seeing you in Las Vegas!
TREATING OPIOID USE DISORDER: SO MUCH MORE THAN MEDICATION #aatod2024 TODAY is the last day to take advantage of the discounted registration rate. #aatod2024 is the world’s premier training conference event for the treatment of #OUD. For registration and hotel information ➡️ bit.ly/3Ue57Q6. We look forward to seeing you in Las Vegas!
3 months ago
View on Instagram |
9/10
#aatod2024 Conference Update. Comprehensive Listing/Descriptions of Workshops, Posters, and Hot Topic Roundtable Conference Sessions are now available ➡️ http://bit.ly/3Ue57Q6.

The workshop committee is pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines. You will hear from experts who will share the latest research and developments relating to opioid use disorders and treatment. The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships and collaborations, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, regulatory changes, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. For those newer to the field or those who want a refresher on the basics, we have once again included a “Foundations” track which will include selections on the fundamentals of medication assisted treatment.

The conference will continue to be the world’s premier training and education event for the treatment of opioid use disorders.  We hope to see you in Las Vegas!
#aatod2024 Conference Update. Comprehensive Listing/Descriptions of Workshops, Posters, and Hot Topic Roundtable Conference Sessions are now available ➡️ http://bit.ly/3Ue57Q6. The workshop committee is pleased to present a dynamic workshop lineup that includes extremely rich and diverse educational content for all disciplines. You will hear from experts who will share the latest research and developments relating to opioid use disorders and treatment. The workshop lineup will include state of the art information on diverse areas of focus such as patient care and best practices, building community partnerships and collaborations, public policy and regulatory changes, workforce development, quality assurance, and financial reimbursement. There will be workshops that focus on emerging treatment trends and developments such as the fentanyl epidemic, mobile opioid treatment programs, regulatory changes, expansion of treatment services in rural areas, integrating treatment with the corrections systems, and integrating harm reduction initiatives. For those newer to the field or those who want a refresher on the basics, we have once again included a “Foundations” track which will include selections on the fundamentals of medication assisted treatment. The conference will continue to be the world’s premier training and education event for the treatment of opioid use disorders. We hope to see you in Las Vegas!
3 months ago
View on Instagram |
10/10

OTPs offer life-saving care beyond methadone services. A recent study found that Hepatitis C virus treatment initiated through OTP telehealth visits resulted in faster adoption of direct-acting antiviral therapy and higher cure rates. Learn more: https://ow.ly/I1NQ50RcE9g

Load More...

#aatod2024 Conference – Las Vegas

COUNTDOWN

2024 Conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram
Stay Connected to AATOD